Drug Trial Radar · NCT07193563
A Study to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder
Last checked: Nov 19, 2026Latest source record: Apr 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
47
Actual
Start
Sep 5, 2025
Primary completion
Mar 19, 2026
Study completion Mar 19, 2026
Sponsor
- Lead sponsor
- Engrail Therapeutics INCIndustry
- Sponsor type
- Industry
- First posted
- Sep 26, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a double-blind study to evaluate the efficacy and safety of ENX-102 in participants with social anxiety disorder (SAD).
Conditions
- Social Anxiety Disorder (SAD)
Interventions
ENX-102Drug
oral capsule
PlaceboOther
oral capsule
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline on the Clinician-administered Liebowitz Social Anxiety Scale (LSAS) - Total scoreTime frame: Baseline (Day 1) and Week 6
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
IMA Clinical Research Phoenix
Phoenix, Arizona
University of California
La Jolla, California
Neuroresearch Group
Los Angeles, California
Excell Research, Inc.
Oceanside, California
Anderson Clinical Research
Redlands, California
California Neuroscience Research, LLC
Sherman Oaks, California
Sunwise Clincial Research
Walnut Creek, California
Mountain View Clinical Research
Denver, Colorado
CNS Health
Jacksonville, Florida
Clinical Neuroscience Solutions, Inc.
Orlando, Florida
CenExel iResearch, LLC
Savannah, Georgia
IMA Clinical Research
Las Vegas, Nevada
Redbird Research
Las Vegas, Nevada
Cenexel HRI
Berlin, New Jersey
SPRI Clinical Trials, LLC
Brooklyn, New York
Neurobehavioral Research, Inc.
Cedarhurst, New York
Clinical Neurosciences, Inc
Memphis, Tennessee
Austin Clinical Trials Partners
Austin, Texas
Grayline Research Center
Wichita Falls, Texas
Core Clinical Research
Everett, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.